Professor Yogesh Kulathu

Chair of Cellular Biochemistry

MRC PPU, School of Life Sciences

Yogesh Kulathu

Contact

Email

[email protected]

Phone

+44 (0)1382 388163

Biography

Yogesh graduated with a Bachelor’s degree in Chemical Engineering in 2000 from Birla Institute of Technology and Science (BITS), Pilani, India. He then went on to do a PhD in Immunology at the Max Planck Institute of Immunobiology and University of Freiburg in Germany under the supervision of Prof. Michael Reth, where he worked on B cell antigen receptor signalling and protein tyrosine kinase regulation. To apply structural biology methods to study cell signalling, Yogesh moved to Cambridge in 2009 to work at the MRC Laboratory of Molecular Biology. He was awarded a Marie Curie Intra-European Fellowship and an EMBO Long term fellowship to work on the structural basis driving linkage specificity in ubiquitin binding domains and in the ovarian tumour (OTU) family of deubiquitinases.

In February 2013, Yogesh relocated to the MRC PPU to establish his research program, focussing on ubiquitin signalling mechanisms. His research focusses on the mechanisms by which cells maintain protein homeostasis. Failure to degrade proteins in a timely manner is the underlying cause of diseases such as cancer and neurodegeneration. By studying how ubiquitylation regulates protein degradation and proteostasis they hope to better understand the molecular causes of disease that can be exploited for the development of effective therapeutic strategies.

In 2015 Yogesh received a prestigious ERC Starting Grant to investigate the function of ubiquitin and ubiquitin-like modifiers regulating T lymphocyte biology. He was selected as a EMBO Young Investigator in 2015. Yogesh is a recipient of the Lister Prize in 2017 from the Lister Institute of Preventive Medicine. In 2021 he received an ERC Consolidator Grant to investigate how branched ubiquitin signals function as priority signals in cellular stress responses. In 2022, he was made the Professor of Cellular Biochemistry.

Research

Our laboratory is interested in understanding how signal transduction is mediated in cells by the posttranslational modification of proteins. A primary focus of the lab is the ubiquitin system where the attachment of ubiquitin can alter the function and fate of the modified protein. By using a multidisciplinary approach, we aim to get mechanistic insights into how fundamental cellular processes are modulated by ubiquitylation to maintain cellular homeostasis. Of late, we have also expanded our research into the poorly studied ubiquitin-like modifier UFM1 which is essential for protein biogenesis and endoplasmic reticulum homeostasis. We aim at getting detailed biochemical and molecular insights into these processes by focussing on the enzymes that add the modification, modules that recognize and decode the modification, and proteases which remove them.

At present, we have 3 focus areas of research in the lab:

  1.  How do different ubiquitin signals couple to different signalling outcomes and how is ubiquitylation regulated by Deubiquitinases (DUBs)?
  2. How are proteins modified with UFM1 and why is this modification essential to maintain ER homeostasis?
  3. How are the IRAK kinases activated and regulated in innate immune signalling?

See here for more details

Selected Recent Publications

View full research profile and publications

Awards

Award Year
Major Personal Funding Awards / ERC Consolidator Grant 2020
Major Personal Funding Awards / Lister Research Prize 2017
International Science Prizes awarded since 1990 / European Molecular Biology Organisation Young Investigator Programme 2016
Major Personal Funding Awards / ERC Starting Grant 2015
International Science Prizes awarded since 1990 / Marie Curie Intra European Fellowship 2010
Personal Fellowships / EMBO Long-Term Fellowship 2009

Stories